Molecular and Cellular Biology, April 2001, p. 2918-2932, Vol. 21, No. 8
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.8.2918-2932.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Departments of Biochemistry1 and Oncology8 and Molecular Oncology Group, Department of Medicine,3 McGill University, Montreal, Quebec, Canada H3G 1Y6; MGH Cancer Center, Charlestown, Massachusetts 021292; Howard Hughes Medical Institute, Division of Nucleic Acids Enzymology, Department of Biochemistry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 088546; Lineberger Comprehensive Cancer Center, Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-72955; H. Lee Moffitt Cancer Center and Research Institute, Molecular Oncology Program, University of South Florida, Tampa, Florida 336124; and Harvard Microchemistry Facility, Harvard University, Cambridge, Massachusetts 021387
Received 31 August 2000/Returned for modification 11 October 2000/Accepted 16 January 2001
| |
ABSTRACT |
|---|
|
|
|---|
Retinoblastoma (RB) tumor suppressor family pocket proteins induce cell cycle arrest by repressing transcription of E2F-regulated genes through both histone deacetylase (HDAC)-dependent and -independent mechanisms. In this study we have identified a stable complex that accounts for the recruitment of both repression activities to the pocket. One component of this complex is RBP1, a known pocket-binding protein that exhibits both HDAC-dependent and -independent repression functions. RB family proteins were shown to associate via the pocket with previously identified mSIN3-SAP30-HDAC complexes containing exclusively class I HDACs. Such enzymes do not interact directly with RB family proteins but rather utilize RBP1 to target the pocket. This mechanism was shown to account for the majority of RB-associated HDAC activity. We also show that in quiescent normal human cells this entire RBP1-mSIN3-SAP30-HDAC complex colocalizes with both RB family members and E2F4 in a limited number of discrete regions of the nucleus that in other studies have been shown to represent the initial origins of DNA replication following growth stimulation. These results suggest that RB family members, at least in part, drive exit from the cell cycle by recruitment of this HDAC complex via RBP1 to repress transcription from E2F-dependent promoters and possibly to alter chromatin structure at DNA origins.
| |
INTRODUCTION |
|---|
|
|
|---|
The retinoblastoma (RB) tumor
suppressor gene product, pRB, regulates transcriptional events
important for cell proliferation (for reviews, see references 17
and 45). A major target of pRB is the E2F family of
transcription factors that control expression of many genes required
for DNA synthesis and cell cycle progression. Binding of pRB to E2F
species inhibits expression of E2F-regulated genes, resulting in
withdrawal from the cell cycle (for reviews, see references 3,
26, and 45). pRB and related pocket proteins p107 and p130
utilize multiple mechanisms to elicit this effect. With certain
promoters, binding via the pocket to the activation domain of E2F
inhibits E2F-mediated transactivation (23, 27, 28). But
this mechanism does not explain how, with other promoters, E2F binding
sites function as negative regulatory elements (13, 31, 47,
61). In these cases, RB family members function as
transcriptional repressors, which utilize E2F proteins as DNA-docking factors. Studies using pRB fused to heterologous DNA binding domains indicated that the pRB pocket functions as an active repressor (1, 7, 52, 61, 62). This repression function, and not
pRB-mediated inhibition of the E2F transactivation domain, was shown
recently to be required for G1 arrest triggered by
transforming growth factor
, p16INK4a, and
contact inhibition (67) and for blockage of the cell cycle by pRB (25, 52). Thus, active repression by RB family
members is important for exit from the cell cycle.
Several mechanisms have been proposed to account for repression by pRB. Dean and coworkers suggested that the pocket might prevent transactivators from interacting with components of the TFIID complex (41, 61). Rose et al. proposed that E2F itself may be affected in this way by the pocket (50). The pocket is now known to interact simultaneously with E2F and other cellular factors, and our work and that of others suggested that RB-binding proteins might utilize conserved LXCXE motifs to recruit repression activities to the pocket (6, 16, 20, 21, 31, 39, 40, 41, 42, 57, 62). Some of the models proposed in these studies (6, 16, 41, 42, 57) stressed the importance of chromatin structure in regulating transcriptional activity (for reviews, see references 4, 36, and 53). Active repression by pRB therefore could involve a mechanism by which condensed chromatin structure is enhanced through the creation of hypoacetylated histones or other target proteins.
Understanding of the enzyme complexes involved in histone acetylation and deacetylation has increased greatly in recent years (for reviews see references 2 and 37). The catalytic subunits (Rpd3, HDA, and HOS) of histone deacetylase (HDAC) complexes from yeast were cloned (8, 51), and several mammalian versions have now been identified within two classes (14, 18, 44, 55, 60, 65, 66). HDAC1, HDAC2, and HDAC3 are class I enzymes that share homology with yeast Rpd3, whereas HDAC4, HDAC5, HDAC6, and HDAC7 are class II enzymes that share homology with yeast HDA1. At least two distinct HDAC complexes (mSIN3-HDAC and NURD) were isolated in mammalian cells (58, 59, 64, 68, 69, 70, 71). Both complexes contain the class I HDACs, HDAC1 and HDAC2. Most of the subunits in the NURD and mSIN3-HDAC complexes have now been identified. Some subunits, like RBAP46, RBAP48, HDAC1, and HDAC2, are present in both complexes; however, the majority of subunits in these complexes are distinct. The NURD complex contains an ATPase subunit, Mi2, MTA2, and MBD3, whereas the mSIN3 contains the mSIN3A/B, SAP30, and SAP18 components (2, 64, 68, 69, 70, 71). The mSIN3-HDAC complexes are recruited by many transcriptional repressors in a pattern evolutionarily conserved from yeasts to humans (32, 54, 71). In contrast to the mSIN3-HDAC complex, the NURD complex is able to deacetylate nucleosomal templates, and it is recruited to methylated DNA, suggesting a role in gene silencing by DNA methylation (46, 59, 69).
The pocket domains of RB family members were shown not long ago to repress E2F-dependent transcription by recruiting HDAC1, HDAC2, and HDAC3 (5, 6, 39, 41, 42). These results suggested that HDACs are important for the active repression function of RB family members. However, drug inhibition studies by our group and others indicated that both HDAC-dependent and -independent activities function at the pocket simultaneously, suggesting that other components are also involved with active repression by RB family proteins (39, 41).
We have previously demonstrated that an LXCXE-containing RB-binding protein, RBP1, functions as an adapter protein by recruiting class I HDACs to the pocket. In addition, RBP1 possesses an HDAC-independent repression activity. Therefore, the recruitment of RBP1 to the pocket provides a model that explains both HDAC-dependent and -independent repression by RB family members (39, 40). Furthermore, it has recently been suggested that RBP1 is present as a component of the mSIN3-HDAC complex (D. Reinberg, unpublished data). In this report, we present evidence that HDAC activity present in the mSIN3-HDAC complex is recruited to RB family members via RBP1 and not via a direct interaction between the pocket and an IXCXE motif found in HDAC1 and HDAC2, as suggested previously (6, 21, 41, 42). We further demonstrate the physiological importance of the recruitment of the mSIN3-HDAC complex by RB family members in quiescent cells.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Plasmids and antibodies. Bacterial expression plasmids expressing glutathione S-transferase (GST)-pRB (379-928), GST-pRB(379-928-C706F), GST-p107(252-936), and GST-p107(252-936-C713F) were gifts from Bill Kaelin and Mark Ewen (19, 33). Plasmid constructs expressing GST-SAP30 and pET28-SAP30 for in vitro translation have been described before (71). pVZmSIN3B and pVZmSIN3A constructs for in vitro translation were gifts from Bob Eisenman. pGEM-RbAp48 and pcDNA3-Flag-HDAC1 plasmids used for in vitro translation were provided by Eva Lee (49) and Ed Seto, respectively. Plasmids expressing GST-HDAC1 and GST-HDAC3 have been described elsewhere (56). All GST fusion proteins with various truncations of RBP1, including GST-R1, GST-R2, GST-ARID, GST-dl1208C, and GST-dl747C, were generated by subcloning cDNAs from the Gal4 fusion mammalian expression plasmids expressing the corresponding mutants (39) into plasmid pGEX-2TK. Plasmid expressing GST-E1A in bacteria was described before (39).
Monoclonal antibodies against RBP1 used in coimmunoprecipitation and immunofluorescence studies (LY11, LY32, and LY48) were gifts from Bill Kaelin and Jim DeCaprio. LY11 and LY32 have been described previously (39, 40). Amino-terminal RBP1 polyclonal antiserum was produced commercially by injecting an amino-terminal RBP1 peptide (CLKQDNTTQLVQDDQVKGPLRV) into rabbits (Genemed Synthesis Inc.). Monoclonal antibody NM11 against p300 was kindly provided by Betty Moran (12). Antibodies against pRB purchased commercially included XZ91 and G3-245 (Pharmingen), IF8 (Santa Cruz Biotechnology), and polyclonal C-15 (Santa Cruz); monoclonal antibody C36 was obtained from Ed Harlow. Rabbit polyclonal antibodies against HDAC1, HDAC2, and HDAC3 were described previously, and goat polyclonal antibodies against HDAC1 (C-19) and HDAC2 (C-19) were purchased from Santa Cruz. Monoclonal antibody 15G12 against RBAP46/48 (GeneTex) and polyclonal antibodies AK11 and AK12 against mSIN3A and mSIN3B, respectively, were purchased from Santa Cruz. Rabbit polyclonal antibody against SAP30 has been described elsewhere (71). Finally, monoclonal antibody against the His6 epitope was purchased commercially (Amersham Pharmacia).Purification of His6-tagged and GST
fusion proteins.
His6-tagged HDAC1, HDAC2, and HDAC3
proteins were purified from SF9 insect cells infected with baculovirus
expressing these proteins under a constitutive promoter (a gift from Ed
Seto and Yi Zhang). All GST fusion proteins and His-SAP30 were purified from Escherichia coli BL21-DE3. Competent bacterial cells
were transformed with pGEX-2TK plasmids containing cDNAs encoding
appropriate proteins. Transformed cells were grown in 2YT medium at
30°C with agitation until the optical density at 595 nm reached 1.2. Isopropyl-
-D-thiogalactopyranoside (50 mg/liter, final
concentration) was used to induce expression of GST fusion proteins for
another 1.5 h. Cells were harvested and lysed by sonication in
buffer B (50 mM Tris-HCl [pH 7.5] containing 200 mM NaCl, 5 mM EDTA,
10 mM mercaptoethanol, 1% [vol/vol] Triton X-100, and 1 mM protease
inhibitor cocktail). GST fusion proteins were isolated from extracts by
incubation with 1 ml of glutathione-Sepharose 4B (Pharmacia) per liter
for 2 to 4 h. Proteins bound to beads were washed six times with
buffer B and eluted by incubation with 20 mM reduced glutathione
(Sigma). Eluted proteins were spin dialyzed and concentrated by
Centricon spin columns (Millipore). Concentrations of purified proteins
were determined by standard Bradford assays.
In vitro binding assays. mSIN3A, mSIN3B, RBAP48, HDAC1, SAP30, and luciferase proteins were labeled and synthesized in the presence of [35S]methionine protein labeling mix (NEN) using the TnT coupled reticulocyte lysate system (Promega). Three-microgram aliquots of GST fusion proteins purified from bacteria were incubated with 5 µl of in vitro-translated proteins with 10 µl of glutathione-Sepharose 4B beads (Pharmacia) in 1 ml of buffer A (1× phosphate-buffered saline, 0.1% NP-40, 1 mM aprotinin, 1 mM leupeptin, 1 mM pepstatin) for 2 h at 4°C. GST pull-down assays were performed using six washes, and the resulting proteins associated with the beads were eluted with 2X sample buffer. Samples were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using gels containing 10% polyacrylamide. Gels were fixed by dimethyl sulfoxide-2,5-diphenyloxazole treatment and then dried and analyzed by autoradiography using Kodak X-Omat film. In vitro binding assays using purified His6-tagged proteins were performed similarly, except that instead of in vitro-translated proteins, 3-µg aliquots of His6-tagged proteins were incubated with 3 µg of GST fusion proteins. GST pull-down assays were performed, and the samples were resolved by SDS-PAGE using 10% polyacrylamide gels. Proteins were then transferred to polyvinylidene difluoride membranes (Millipore), which were probed with anti-His6 monoclonal antibody (Amersham Pharmacia) and then by horseradish peroxidase-conjugated goat anti-mouse secondary antibody (Jackson Laboratories). Binding was detected by enhanced Luminol reagent (NEN Life Science).
HDAC assays. Three-microgram aliquots of GST proteins purified from bacteria were incubated with H1299 cell nuclear extracts in 10 µl of glutathione-Sepharose 4B beads (Pharmacia). GST pull-down assays were performed, and the resulting beads were incubated with 10,000 cpm of 3H-labeled histones extracted from HeLa cells, as described previously (60), in 0.1 ml of buffer H (50 mM Tris-HCl [pH 7.5] containing 100 mM NaCl, 0.1 mM EDTA, and 0.1 mM phenylmethylsulfonyl fluoride). The reaction mixtures were incubated at 37°C for 2 h, and reactions were stopped by the addition of 50 µl of 0.1 M HCl-0.16 M acetic acid solution. Then 0.5 ml of ethyl acetate was used to extract [3H]acetate. The resulting mixtures were separated into aqueous and organic phases by centrifugation, and 0.4 ml of the upper organic phase was quantified by scintillation counting.
Immunodepletion. Lysates from one half of a 150-mm-diameter plate of H1299 cells were incubated with 5 to 10 µl of antibody in 10 µl of protein G- or protein A-Sepharose in buffer A containing 1 µM protease inhibitor cocktail for 4 h at 4°C. Immunoprecipitated proteins were washed six times with buffer A and subjected to HDAC assays to detect HDAC activity. The remaining lysates were subjected to another round of immunoprecipitation using the same quantity of antibodies and fresh protease inhibitor cocktails. Between 7 to 10 rounds of immunodepletion were performed until background levels of HDAC activity were detected. Such lysates were incubated with 100 µl of Pansorbin cells (Calbiochem) for another 4 h at 4°C to remove excess antibodies. These extracts were used to detect associated HDAC activity.
In vivo binding assays. H1299 cells were cultured, harvested, and lysed as described before (39). Five to 10 µl of antibody against different endogenous proteins was used to perform immunoprecipitations using lysates from 150-mm-diameter plates of cells. Immunoprecipitation was performed at 4°C for 12 h, and samples were washed and eluted as described previously (39). Associating proteins were detected by Western blot analysis using appropriate antibodies.
Immunofluorescence. WI38 cells were seeded on plates containing coverslips and serum-starved in Dulbecco modified Eagle medium containing 0.1% fetal bovine serum for 72 h. Cells were incubated with cell proliferation labeling reagents containing bromodeoxyuridine (BrdU) and fluorodeoxyuridine (Amersham), fixed in 4% paraformaldehyde, and permeabilized in 1× phosphate-buffered saline containing 0.5% Triton X-100. Indirect immunofluorescence was performed using a monoclonal antibody against BrdU (Amersham). Fluorescein- or Texas red-conjugated secondary antibodies (Vector Laboratories) were used to detect BrdU incorporation. Cells were visualized under a light microscope and counted to evaluate BrdU incorporation. No BrdU staining was detected in serum-starved cells, whereas significant amounts of staining were detected in asynchronously growing cells. To detect the staining patterns of endogenous proteins, appropriate mouse monoclonal and rabbit polyclonal antibodies were used, and the same fluorescein- or Texas red-conjugated secondary antibodies (Vector Laboratories) were employed to detect staining. Imaging was performed using a charge-coupled device (CCD) digital camera and deconvolution microscopy using a 100× objective lens (Scanalytics).
| |
RESULTS |
|---|
|
|
|---|
RB family members do not interact directly with HDAC.
All
members of the RB family of proteins appear to associate with class I
HDACs, including HDAC1, HDAC2, and HDAC3 (6, 21, 39, 41,
42). A direct association between HDAC1 and RB family proteins
has been suggested, based on interactions observed between purified
GST-RB and in vitro-translated HDAC1 (21, 42). To examine
the interaction between RB family proteins and HDAC1 further, we
synthesized GST-pRB(pocket) and GST-p107(pocket) proteins in bacteria
and combined each purified product with purified histidine-tagged HDAC1
isolated from SF9 insect cells infected with a baculovirus that
overexpressess His6-HDAC1. Although we believe that results similar to those described below would be obtained using the pocket of
p130, we have not been successful in obtaining suitable p130(pocket) material to conduct this type of experiment. Following incubation of
GST fusion proteins in vitro with purified HDAC1, we performed GST
pull-down experiments and detected associations by Western blotting
using anti-His antibody. Figure 1A
shows that no interaction between purified HDAC1 and
the pocket of either pRB or p107 was detectable; however, addition of
nuclear extract along with the purified proteins resulted in a
significant amount of association. These results differed from previous
assessments in that they suggested that another nuclear factor(s) could
act as a bridge in this in vitro interaction. Similar results were also
obtained using purified HDAC3 (data not shown). The association
observed previously (and demonstrated below in Fig. 6B) between pRB and in vitro-translated HDAC1 had been proposed to occur via interactions between the pocket and a degenerate IXCXE motif in HDAC1 (21, 42). Because HDAC3 lacks such a motif, HDAC3 must require other factors to associate with the pRB pocket, and the data in Fig. 1
suggest that such is also the case with HDAC1. An explanation for the
disparity between our results and those reported previously might
relate to the fact that in vitro-translated HDAC1 is defective in HDAC
activity, whereas HDAC1 purified from SF9 cells has been shown to be
enzymatically active (43). But the simplest interpretation is that both HDAC1 and HDAC3 require an additional linker protein present both in nuclear extracts and the in vitro translation mixture
used in the earlier studies. While we cannot exclude the possibility
that the pocket can bind directly to HDACs via the IXCXE motif, this
interaction may not represent the major mechanism of binding between RB
family members and HDACs.
|
RBP1 is a factor that recruits HDAC activity to RB family
members.
We have demonstrated previously that the RB-binding
protein RBP1 may function as a bridging factor to recruit class I HDACs (39). Studies were therefore conducted to estimate the
importance of RBP1 in this association. GST-pRB fusion proteins were
shown previously to be able to recruit HDAC activity from nuclear
extracts (6, 42). We have modified this assay by
immunodepleting RBP1 from nuclear extracts using an anti-RBP1 antibody,
LY11, and then incubating such extracts with GST-pRB protein. As shown
in Fig. 1C, after seven rounds of immunodepletion with LY11 virtually no detectable RBP1 remained, as determined by Western blotting of
samples containing equal amounts of protein using another anti-RBP1 antibody, LY32. With extracts depleted using nonspecific rabbit serum
(NRS), significant amounts of RBP1 remained. Figure 1C also shows that
such immunodepletion caused little change in the levels of another
nuclear protein, HMG1. Samples were then subjected to GST pull-down
analysis and assessed directly for HDAC activity to quantify the level
of HDAC following LY11 or NRS immunodepletion. Figure 1B shows that
significant amounts of HDAC activity were associated with the pocket of
pRB and p107 after immunodepletion with NRS; however, with both pRB and
p107, HDAC activity decreased to less than half that in samples
immunodepleted with LY11 anti-RBP1. These results suggested that
RBP1-associated HDAC activity constitutes a significant proportion of
the HDAC activity associated with RB family members. It was possible
that this effect might have resulted from a depletion of the overall
pool of HDAC activity in the extract; however, no similar loss of
RB-associated HDAC activity was observed with extracts immunodepleted
using antibodies against individual class I HDACs that removed an even
greater fraction of the overall HDAC pool (Fig.
2 and data not shown). The inability to
abolish RB-associated HDAC activity completely may suggest that RBP1
may not be the only bridging factor recruiting HDACs to RB family
members. This contention is consistent with other findings that showed
that RBAP48, another RB-binding protein, and c-Ski, an LXCXE-containing
RB-binding protein, are also able to recruit HDAC1 to RB family members
(56; B. K. Kennedy, personal communication). In
addition, the failure to abolish all activity could result from the
fact that RBP1 exists in multiple isoforms (48), not all
of which may be recognized by antibody LY11.
|
R2 but not the R1 region of RBP1 recruits HDAC to the pocket of RB. To determine if the HDAC activity associated with RB family members is dependent on the pocket, point mutants of pRB (C706F) and p107 (C713F), which abolish binding of RBP1 (Fig. 4C and data not shown), were used to detect pRB- and p107-associated HDAC activities. Figure 1D shows that both mutants were unable to recruit significant levels of HDAC activity, indicating that a functional pocket domain is of great importance for the association. We have shown previously that association of class I HDACs with RBP1 requires the R2 but not the R1 repression domain of RBP1. Consistent with our previous results, Figure 1D shows that R2 recruited high levels of HDAC activity, whereas R1 associated only with background levels. Thus, repression by R1 does not involve HDACs that are measurable by the present assay or that are inhibited by the HDAC inhibitor trichostatin A (TSA). All HDAC activity associated with RB family members or the R2 repression domain of RBP1 was inhibited by TSA (data not shown), in keeping with our previous in vivo repression studies (39). In addition, transcriptional repression activities associated with pRB and full-length RBP1 are known to be only partially sensitive to TSA (39, 41), suggesting that repression by RB family members may also utilize the HDAC-independent activity associated with the R1 repression domain of RBP1.
pRB and RBP1 recruit only class I HDAC activities. Both RB family members and RBP1 have been shown to associate with the class I HDACs, HDAC1, HDAC2, and HDAC3. To determine if either can associate with other HDACs (class II or unidentified HDACs), experiments similar to those in Fig. 1B were performed except that antibodies against specific class I HDAC species were used in seven rounds of immunodepletion. Western blotting analysis shown in Fig. 2C indicated that antibodies against either HDAC1 or HDAC2 depleted both of these species but not much HDAC3. Similar results were obtained with a mixture of anti-HDAC1 and anti-HDAC2 sera. This observation was consistent with the idea that HDAC1 and HDAC2 are present together as a complex. Anti-HDAC3 antibodies depleted not only HDAC3 but also some amounts of HDAC1, but not HDAC2. This observation suggested that human H1299 cells may contain complexes involving both HDAC1 and HDAC3, unlike Jurkat and HeLa cells studied previously (24). Addition of a mixture of antibodies against all three class I enzymes eliminated all three but had little effect on the control nuclear protein HMG1. Figure 2A shows that immunodepletion using any single anti-class I HDAC antibody had only a small effect on the levels of HDAC activity associated with pRB, whereas treatment with a mixture of antibodies recognizing all three eliminated essentially all of the pRB-associated HDAC activity. Almost identical results were obtained using the R2 domain of RBP1 (Fig. 2B), indicating that both pRB and RBP1 associate with HDAC1, HDAC2, and HDAC3 but not with other members of the HDAC family, including class II enzymes, which we have found are abundant in the extracts used in these experiments (data not shown). Furthermore, immunoprecipitation experiments using antibodies against HDAC4 and HDAC6 did not coimmunoprecipitate any RBP1 or RB family members (data not shown). These data strengthen the idea that RBP1 plays an important role as a bridge between RB family members and class I HDACs.
RBP1 recruits the mSIN3-HDAC complex.
Mammalian cells contain
two known class I HDAC complexes, the mSIN3-related and NURD HDAC
complexes (58, 59, 64, 68, 69, 70, 71). Antibodies against
mSIN3 and the SAP30 component of the mSIN3A-HDAC complex were used to
determine the association between RBP1 and this complex. Figure
3A shows that RBP1 was
coimmunoprecipitated from nuclear extracts with AK11 (anti-mSIN3A) and
AK12 (anti-mSIN3B) antibodies. Interestingly, large amounts of RBP1
were also detected using anti-SAP30 antibodies. An antibody that
recognizes the p300 histone acetyltransferase (NM11)
did not coimmunoprecipitate any RBP1 from these extracts. Figure 3B
shows that immunoprecipitation of RBP1 using antibody LY11 results in
the coprecipitation of mSIN3A, mSIN3B, low levels of pRB, and HDAC1. In
addition, Figure 3C shows that another component of all class I HDAC
complexes, RBAP46/48, is also present in immunoprecipitates prepared
using anti-RBP1 or anti-pRB antibodies but not with those against p300. HDAC activity was also measured directly using these
immunoprecipitates, and significant levels were detected using antibody
LY11 but not with anti-p300 antibody NM11 (data not shown). These
results indicated that RBP1 associates with the mSIN3-HDAC complex in
vivo.
|
R2 repression domain recruits mSIN3-HDAC complex.
We generated
a series of RBP1 deletion mutants and expressed them as GST fusion
proteins (Fig. 4B). Using these mutant
GST-RBP1 proteins as well as GST fusion products containing either
SAP30 or adenovirus E1A protein, the binding of components of the
mSIN3-HDAC complex was examined further. Figure 4A shows that the only
RBP1 product that associated with mSIN3B and HDAC1 was GST-R2, thus confirming that the R2 region is uniquely responsible for binding of
the mSIN3-HDAC complex to RBP1. This finding was further strengthened by results shown in Fig. 4C, which indicated that GST-R2 but not GST-R1
was able to bind to mSIN3B, RBAP46/48, HDAC1/2, and Sap30 present in
nuclear extracts. In addition, Fig. 4C shows that both GST-pRB and
GST-p107 recognized these same components of the mSIN3-HDAC complex.
Failure of such binding by the pRB pocket mutant C706F confirmed the
requirement of the pocket for this association with RBP1 and the
mSIN3-HDAC complex. These experiments demonstrated that the R2
repression domain of RBP1 is responsible for recruiting the entire
mSIN3-HDAC complex.
|
RBP1 binds to HDAC via SAP30.
To identify the protein that is
directly responsible for binding of the mSIN3-HDAC complex to the R2
domain of RBP1, purified GST-R2 protein was incubated in vitro with
various components of the complex, and binding was assessed in GST
pull-down experiments as in Fig. 4. Figure
5A shows results obtained by Western
blotting using anti-His antibody and indicated that His6
HDAC1, which had been synthesized in and purified from SF9 insect
cells, failed to associate with RBP1-R1 or with a deletion mutant of
RBP1 (dl 1208C) that lacks the carboxy-terminal R2 domain, even in the presence of nuclear extracts. Binding was not apparent with the R2
domain either, unless nuclear extract was added. These results suggested that HDAC1 does not interact directly with R2 but rather does
so via another factor found in nuclear extracts. Figure 5B shows
results of similar experiments carried out with other components of the
mSIN3-HDAC complex which had been translated in vitro using appropriate
cDNAs in rabbit reticulocyte lysates in the presence of
[35S]methionine and detected by autoradiography following
SDS-PAGE. Interestingly, only in vitro-translated SAP30 was able to
associate with the R2 domain of RBP1. Some level of association of
HDAC1 with GST-pRB in a pocket -dependent manner was also observed, as
also seen by others. It should be noted that SAP30 did not interact
with GST-dl747C, a truncation mutant of RBP1 that contains R1 but not
R2, nor with GST-pRB, suggesting that utilizing R2, RBP1 truly
functions as a bridge to recruit mSIN3-HDAC complex to the pocket of
pRB. To strengthen this contention further, various GST fusion proteins
and His-SAP30 were synthesized in and purified from bacteria and
incubated together in vitro. GST pull-down assays were performed, and
binding of His-SAP30 was assessed by Western blotting using anti-His
antibody. GST-HDAC1 was demonstrated previously by others to bind
directly with SAP30 (71) and was used as a positive
control in this experiment. Figure 5C shows that GST-R2 interacted
directly with purified SAP30 protein as did GST-HDAC3; however, GST-R1,
GST-pRB, and GST alone did not. These results indicated that the
association of the mSIN3-HDAC complex with the R2 domain of RBP1 likely
occurs via SAP30. In addition, the association seen between HDAC3 and
SAP30 in vitro may suggest that there exists a pool of mSIN3-SAP30-HDAC
complex that contains HDAC3 as a subunit. This observation further
supported results in Fig. 2C, which suggested that there may be a pool
of complex containing both HDAC1 and HDAC3 as subunits that constitute
part of the HDAC activity recruited by pRB and RBP1.
|
RBP1 and RB family members require SAP30 to recruit HDAC
activity.
To determine if SAP30 is essential for pRB and p107 to
recruit HDAC activity, an immunodepletion study similar to that
described in Fig. 1B was carried out using a polyclonal antibody that
recognizes SAP30. Figure 6B shows that
anti-SAP30 antibody removed SAP30 from the extracts while not affecting
levels of the control nuclear protein HMG1. As shown in Fig. 6A,
immunodepletion of SAP30 completely abolished the association of HDAC
activity with the R2 domain of RBP1. Consistent with our earlier
results with RBP1 immunodepletion, more than half of the HDAC activity
recruited by the pockets of both p107 and pRB was abolished in
SAP30-depleted extracts. This experiment therefore demonstrated that
the SAP30-containing mSIN3-HDAC complex recruited by the R2 region of
RBP1 is responsible for at least 50% of the HDAC activity present at
the pocket of RB family members.
|
pRB colocalizes with RBP1 and mSIN3-HDAC complex in quiescent
cells.
The biochemical evidence presented in this study suggested
that pRB-E2F complexes can recruit mSIN3-HDAC complex via RBP1. If such
complexes exist in vivo, individual components should colocalize in
cells within the nucleus. To determine the relative cellular
localization of RBP1 and various binding partners, quiescent primary
human diploid fibroblasts were studied because we previously detected
pRB-RBP1-E2F complexes in growth-arrested cells (40). WI38
human diploid fibroblasts were serum starved for 3 days, and BrdU
incorporation studies were performed to determine if the cells had
exited the cell cycle. Immunofluoresence studies were also performed
using various monoclonal and polyclonal antibodies against BrdU, RBP1,
pRB, E2F4, HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, mSIN3A, and SAP30.
High-resolution deconvolution microscopy utilizing a CCD digital camera
was used to image these stained cells. Figure 7A shows that using two
different monoclonal antibodies (LY32 and LY48) and one
polyclonal (amino-terminal) antibody against RBP1, similar staining
patterns showing very discrete regions within nuclei were observed in
these cells. When the green and red channels were merged, the yellow
spots represented the highest concentrations of RBP1, and thus the most
representative of the true location of RBP1. BrdU staining was not
detected in these cells, indicating that they were in full growth
arrest (data not shown). Figure 7B shows that pRB,
p130, and E2F4 also colocalized in these RBP1-containing discrete
nuclear regions. Similar studies were not carried out with p107, as we
and others have found p107 levels to be undetectable in quiescent cells
(10, 40). As shown in separate colocalization studies
(35; B. K. Kennedy, D. A. Barbie, A. Lai, M. Classon, N. Dyson, P. E. Branton, and E. Harlow, unpublished
results). these regions appear to occupy perinucleolar sites and do not
appear to be those containing promyelocytic leukemia (PML) bodies.
Rather, these same regions were found to contain the initial origins of
DNA replication following serum stimulation (35; Kennedy
et al., unpublished) (see Discussion). As biochemical studies implied a
specific association of RBP1 with class I HDACs, similar colocalization
studies were performed comparing RBP1 to HDAC1 to -3. Figure 7C shows
that HDAC2 also largely colocalizes to these discrete RBP1-containing
regions, as did HDAC1 and HDAC3 (data not shown). Interestingly, Figure 7C also shows that class II HDAC4 and HDAC6 exhibit quite different staining patterns and did not colocalize with RBP1 at significant levels, as was consistent with our immunodepletion studies. Finally, and consistent with the previous biochemical data, Figure 7D shows that
a significant number of stained foci of both mSIN3A and SAP30 also
colocalized with RBP1. These results confirmed that RBP1 exists in
resting cells in association with pRB, p130, and components of the
mSIN3-HDAC complex.
|
| |
DISCUSSION |
|---|
|
|
|---|
Active repression function of pRB requires RBP1.
This study
demonstrates the role of RBP1 as a bridging factor that recruits
mSIN3-HDAC complexes to the pocket of RB family members. One of the
important biological functions of the RB family is to regulate
expression of genes required for cell cycle progression and DNA
synthesis. RB family members utilize the pocket domain to recruit HDAC
activities to repress transcription of these genes in early
G1 or when cells exit the cell cycle. We have provided evidence here that RB family members are able to recruit the mSIN3-HDAC complex via a pocket -dependent association with RBP1 to actively repress transcription. Although not all of the HDAC activity associated with pRB can be accounted for by the recruitment of RBP1 as a corepressor, this mechanism may account for over half of such activity.
The remaining activity may associate through interactions with other
bridging factors, possibly including RBAP46/48 and c-Ski, or some
other, unidentified pocket-binding protein that associate with HDAC
complexes. Nonetheless, RBP1 is the first molecule described that
appears to contribute two separate classes of transcriptional
repression activities important for transcriptional repression by RB
family members, both by recruiting the mSIN3-HDAC complex via R2 and
via an as yet unidentified repression mechanism utilizing the R1 domain
(Fig. 8). These dual repression
activities of RBP1 may account for the ability of pRB to repress
transcription in a variety of promoters, including those that have been
reported to be insensitive or only partially sensitive to the HDAC
inhibitor TSA.
|
pRB and p130 recruit the RBP1-mSIN3-HDAC complex in quiescent cells. In previous studies we had detected stable p130-E2F-RBP1 and pRB-E2F-RBP1 complexes capable of binding consensus E2F-specific DNA sequences in quiescent cell extracts (40). Consistent with these previous findings, we have now found that in quiescent cells, RBP1 and mSIN3-HDAC complexes colocalize to regions of the nucleus containing RB family members and E2F4. Other studies (35; Kennedy et al., unpublished) indicated that pRB redistributes to other regions of the nucleus later in the cell cycle and that it no longer colocalizes with either class I HDAC or RBP1 in cells in late S phase. Such observations suggest that induction of gene expression required for S-phase progression may involve a mechanism that relocates the RBP1-mSIN3-HDAC complexes. One interesting finding was that class II HDACs had very different staining patterns and did not colocalize with RBP1 or RB family members. This observation distinguishes the pRB- or RBP1-mediated mechanism of transcriptional repression from that of nuclear hormone receptors, which appear to utilize both classes of HDACs (29, 34).
It was also observed that SAP30 does not colocalize perfectly with RBP1, despite the fact that RBP1 recruitment of HDAC activity absolutely requires the presence of SAP30. These results suggested that not all SAP30-containing complexes contain RBP1; consistent with this notion, SAP30 was also found in HDAC complexes involved in the action of nuclear hormone receptors through association with NCoR/SMRT and in other complexes (38). SAP30-containing complexes may be involved in multiple cellular processes, whereas RBP1-containing SAP30-HDAC complexes may specifically function with RB family members.Model of cell cycle exit and progression control by RB family
members.
Zhang et al. had previously demonstrated the importance
of the transcriptional repression function of pRB in cells induced into
growth arrest by p16, contact inhibition, or transforming growth factor
(67). Their work suggested that blocking of E2F
transactivation by pRB is not sufficient to induce such growth arrest.
Here we have presented evidence that a complex containing HDAC activity
associates with RB family members in quiescent cells. This complex
appeared to be largely the previously identified mSIN3-SAP30-containing
HDAC complex that also contains a newly identified subunit, RBP1, which
appears to bridge it to RB family members. Figure 8 illustrates this
new model in which RB family members induce growth arrest by recruiting
the mSIN3-HDAC complex to the pocket via a direct association with the
RBP1 subunit of the complex. Biochemical evidence presented in this
study suggested that RBP1 contacts SAP30 directly via the R2 repression
domain, whereas SAP30 interacts directly with HDAC1 and HDAC2 within
the complex. RBAP46 and RBAP48, which are also found in the complex, may also have contacts with regions of pRB; however, experiments in
Fig. 4 and 5B and those by others (Kennedy, personal communication) failed to detect any interaction in vitro between pRB and RBAP48. mSIN3A and mSIN3B do not interact directly with RBP1 and may be associated with RBP1 through direct interactions with SAP30 and SAP18.
The precise functions of individual components of this complex in
transcriptional repression function are still unclear, but RBP1 may
serve to target this complex to pRB and also provide a second
HDAC-independent repression activity that may be of critical importance
in some cases. Further studies to address this issue are under way.
| |
ACKNOWLEDGMENTS |
|---|
We thank Bill Kaelin and Jim DeCaprio for providing monoclonal antibodies against RBP1. We also thank Eva Lee, Betty Moran, and Bob Eisenman for providing additional reagents. Wei-Ming Yang and Ed Seto provided class I HDAC-related reagents; those for class II HDAC were from Xiang Jiao Yang and Nick Bertos. Deconvolution microscopy was performed at the Whitehead Institute Microscopy Facility.
This work was supported through grants to P.E.B. from the National Cancer Institute of Canada and the Canadian Institutes for Health Research and to D.R. from NIH (GM485180) and the HHMI. A. L. is the recipient of Terry Fox Biomedical Studentship supported by National Cancer Institute of Canada. M.-C.T is supported by a scholarship from the Fonds pour la Formation de Chercheurs et l' Aide à la Recherche (FRSQ-FCAR-Santé). B.K.K. is supported by a Leukemia Society of America Fellowship, D.A.B. is supported by a Karen Grunebaum Cancer Research Fellowship, and Y.Z. is supported by an NIH Fellowship.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Biochemistry, McGill University, McIntyre Medical Building, 3655 Drummond St., Montreal, Quebec, Canada H3G 1Y6. Phone: (514) 398-7268. Fax: (514) 398-7384. E-mail: branton{at}med.mcgill.ca.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Adnane, J.,
Z. Shao, and P. D. Robbins.
1995.
The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter.
J. Biol. Chem.
270:8837-8843 |
| 2. | Ayer, D. E. 1999. Histone deacetylases: transcriptional repression with SINers and NuRDs. Trends Cell Biol. 9:193-198[CrossRef][Medline]. |
| 3. | Bernards, R. 1997. E2F: a nodal point in cell cycle regulation. Biochim. Biophys. Acta 1333:M33-M40[Medline]. |
| 4. | Björklund, S., G. Almouzni, I. Davidson, K. P. Nightingale, and K. Weiss. 1999. Global transcription regulators of eukaryotes. Cell 96:759-767[CrossRef][Medline]. |
| 5. | Brehm, A., and T. Kouzarides. 1999. Retinoblastoma protein meets chromatin. Trends Biochem. Sci. 24:142-145[CrossRef][Medline]. |
| 6. | Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601[CrossRef][Medline]. |
| 7. | Bremner, R., B. L. Cohen, M. Sopta, P. A. Hamel, C. J. Ingles, B. L. Gallie, and R. A. Phillips. 1995. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15:3256-3265[Abstract]. |
| 8. |
Carmen, A. A.,
S. E. Rundlett, and M. Grunstein.
1996.
HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex.
J. Biol. Chem.
271:15837-15844 |
| 9. |
Chen, T. T., and J. Y. Wang.
2000.
Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function.
Mol. Cell. Biol.
20:5571-5580 |
| 10. | Corbeil, H. B., and P. E. Branton. 1997. Characterization of an E2F-p130 complex formed during growth arrest. Oncogene 15:657-668[CrossRef][Medline]. |
| 11. |
Dahiya, A.,
M. R. Gavin,
R. X. Luo, and D. C. Dean.
2000.
Role of the LXCXE binding site in Rb function.
Mol. Cell. Biol.
20:6799-6850 |
| 12. | Dallas, P. B., P. Yaciuk, and E. Moran. 1997. Characterization of monoclonal antibodies raised against p300: both p300 and CBP are present in intracellular TBP complexes. J. Virol. 71:1726-1731[Abstract]. |
| 13. | Dalton, S. 1992. Cell cycle regulation of the human cdc2 gene. EMBO J. 11:1797-1804[Medline]. |
| 14. | Dangond, F., D. A. Hafler, J. K. Tong, J. Randall, R. Kojima, N. Utku, and S. R. Gullans. 1998. Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells. Biochem. Biophys. Res. Commun. 242:648-652[CrossRef][Medline]. |
| 15. |
Dick, F. A.,
E. Sailhamer, and N. J. Dyson.
2000.
Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
Mol. Cell. Biol.
20:3715-3727 |
| 16. | Dunaief, J. L., B. E. Strober, S. Guha, P. A. Khavari, K. Alin, J. Luban, M. Begemann, G. R. Crabtree, and S. P. Goff. 1994. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79:119-130[CrossRef][Medline]. |
| 17. |
Dyson, N.
1998.
The regulation of E2F by pRB-family proteins.
Genes Dev.
12:2245-2262 |
| 18. |
Emiliani, S.,
W. Fischle,
C. Van Lint,
Y. Al-Abed, and E. Verdin.
1998.
Characterization of a human RPD3 ortholog, HDAC3.
Proc. Natl. Acad. Sci. USA
95:2795-2800 |
| 19. | Ewen, E. M., Y. G. Xing, J. B. Lawrence, and D. M. Livingston. 1991. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164[CrossRef][Medline]. |
| 20. |
Fattaey, A. R.,
E. Harlow, and K. Helin.
1993.
Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
Mol. Cell. Biol.
13:7802-7812 |
| 21. |
Ferreira, R.,
L. Magnaghi-Jaulin,
P. Robin,
A. Harel-Bellan, and D. Trouche.
1998.
The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
Proc. Natl. Acad. Sci. USA
95:10493-10498 |
| 22. |
Flemington, E. K.,
S. H. Speck, and W. G. J. Kaelin.
1993.
E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
Proc. Natl. Acad. Sci. USA
90:6914-6918 |
| 23. |
Hamel, P. A.,
R. M. Gill,
R. A. Phillips, and B. L. Gallie.
1992.
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.
Mol. Cell. Biol.
12:3431-3438 |
| 24. |
Hassig, C. A.,
J. K. Tong,
T. C. Fleischer,
T. Owa,
P. G. Grable,
D. E. Ayer, and S. L. Schreiber.
1998.
A role for histone deacetylase activity in HDAC1-mediated transcriptional repression.
Proc. Natl. Acad. Sci. USA
95:3519-3524 |
| 25. |
He, S.,
B. L. Cook,
B. E. Deverman,
U. Weihe,
F. Zhang,
V. Prachand,
J. Zheng, and S. J. Weintraub.
2000.
E2F is required to prevent inappropriate S-phase entry of mammalian cells.
Mol. Cell. Biol.
20:363-371 |
| 26. | Helin, K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:28-35[CrossRef][Medline]. |
| 27. |
Helin, K.,
E. Harlow, and A. Fattaey.
1993.
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein.
Mol. Cell. Biol.
13:6501-6508 |
| 28. |
Hiebert, S. W.
1993.
Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression.
Mol. Cell. Biol.
13:3384-3391 |
| 29. |
Huang, E. Y.,
J. Zhang,
E. A. Miska,
M. G. Guenther,
T. Kouzarides, and M. A. Lazar.
2000.
Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway.
Genes Dev.
14:45-54 |
| 30. |
Ikeda, M. A., and J. R. Nevins.
1993.
Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
Mol. Cell. Biol.
13:7029-7035 |
| 31. |
Johnson, D. G.,
K. Ohtani, and J. R. Nevins.
1994.
Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.
Genes Dev.
8:1759-1771 |
| 32. | Kadosh, D., and K. Struhl. 1997. Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters. Cell 89:365-371[CrossRef][Medline]. |
| 33. | Kaelin, W. J., D. C. Pallas, J. A. DeCaprio, F. J. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64:521-532[CrossRef][Medline]. |
| 34. |
Kao, H.-Y.,
M. Downes,
P. Ordentlich, and R. M. Evans.
2000.
Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression.
Genes Dev.
14:55-66 |
| 35. |
Kennedy, B. K.,
D. A. Barbie,
N. Dyson, and E. Harlow.
2000.
Nuclear organization of DNA replication in primary mammalian cells.
Genes Dev.
14:2855-2868 |
| 36. |
Kingston, R. E., and G. J. Narlikar.
1999.
ATP-dependent remodeling and acetylation as regulators of chromatin fluidity.
Genes Dev.
13:2339-2352 |
| 37. | Kouzarides, T. 1999. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9:40-48[CrossRef][Medline]. |
| 38. | Laherty, C. D., A. N. Billin, R. M. Lavinsky, G. S. Yochum, A. C. Bush, J. M. Sun, T. M. Mullen, J. R. Davie, D. W. Rose, C. K. Glass, M. G. Rosenfield, D. E. Ayer, and R. N. Eisenman. 1998. SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors. Mol. Cell 2:33-42[CrossRef][Medline]. |
| 39. |
Lai, A.,
J. M. Lee,
W. M. Yang,
J. A. DeCaprio,
W. G. Kaelin, Jr.,
E. Seto, and P. E. Branton.
1999.
RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins.
Mol. Cell. Biol.
19:6632-6641 |
| 40. | Lai, A., R. C. Marcellus, H. B. Corbeil, and P. E. Branton. 1999. RBP1 induces growth arrest by repression of E2F-dependent transcription. Oncogene 18:2091-2100[CrossRef][Medline]. |
| 41. | Luo, R. X., A. A. Postigo, and D. C. Dean. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473[CrossRef][Medline]. |
| 42. | Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche, and A. Harel-Bellan. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-605[CrossRef][Medline]. |
| 43. | Martínez-Balbás, M. A., U.-M. Bauer, J. S. Nielsen, A. Brehm, and K. Kouzarides. 2000. Regulation of E2F1 activity by acetylation. EMBO J. 19:662-671[CrossRef][Medline]. |
| 44. | Miska, E. A., C. Karlsson, E. Langley, S. J. Nielsen, J. Pines, and T. Kouzarides. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099-5107[CrossRef][Medline]. |
| 45. | Nevins, J. R. 1998. Toward an underst |